PURPOSE: Multiple sclerosis (MS) manifests itself in a wide range of symptoms. Physiotherapy plays an important role in the treatment of those symptoms connected with mobility. For this therapy to be at its most effective it should be based on a systematic examination that is able to describe and classify damaged clinical functions meaningfully. The purpose of this study was to develop and validate a battery of tests and composite tests that can be used to systematically evaluate clinical features of MS treatable by physiotherapy. METHODS: The authors assembled a proposed battery of tests comprising known, standard, and validated assessments (low-contrast letter acuity testing; the Motricity Index; the Modified Ashworth Scale; the Berg Balance Scale; scales of postural reactions, tremor, dysdiadochokinesia, and dysmetria; the Nine-Hole Peg Test; the Timed 25-Foot Walk; and the 3-minute version of the Paced Auditory Serial Addition Test) and one test (knee hyperextension) of the authors' own. Normalization was calculated and six composite assessments were measured. Seventeen ambulatory subjects with MS were tested twice with the assessment set before undergoing physiotherapy, and 12 were also tested with the assessment set after the physiotherapy. The test-retest reliability, stability, internal consistency of composite measurements, sensitivity to changes after therapy, and correlation between measurements and the Kurtzke Expanded Disability Status Scale score were evaluated for all tests in the assessment set. RESULTS: A good internal consistency was confirmed for all tests in the proposed battery, and most of the tests also showed good test-retest reliability. While no significant changes occurred without treatment, significant posttreatment improvement was proved in all tests except for low-contrast letter acuity testing, where only a trend to improvement was proved. CONCLUSION: The proposed assessment set is a good tool for the evaluation of clinical features of MS treatable by physiotherapy. This battery of tests is applicable in both clinical practice and research.

Department of Rehabilitation 3 Faculty of Medicine Charles University Prague and Faculty Hospital Královské Vinohrady Prague Czech Republic;

Zobrazit více v PubMed

Thompson AJ. Symptomatic management and rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2001;71(Suppl 2):ii22–ii27. PubMed PMC

Henze T, Rieckmann P, Toyka KV, for Multiple Sclerosis Therapy Consensus Group of the German Multiple Sclerosis Society Symptomatic treatment of multiple sclerosis. Eur Neurol. 2006;56(2):78–105. PubMed

Khan F, Turner-Stokes L, Ng L, Kilpatrick T. Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev. 2007;2:CD006036. PubMed PMC

Thompson AJ. Neurorehabilitation in multiple sclerosis: foundations, facts and fiction. Curr Opin Neurol. 2005;18(3):267–271. PubMed

Thompson AJ. The effectiveness of neurological rehabilitation in multiple sclerosis. J Rehabil Res Dev. 2000;37(4):455–461. PubMed

Haigh R, Tennant A, Biering-Sørensen F, et al. The use of outcome measures in physical medicine and rehabilitation within Europe. J Rehabil Med. 2001;33(6):273–278. PubMed

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology. 1983;33(11):1444–1452. PubMed

McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol. 2001;50(1):121–127. PubMed

Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97–113. PubMed

Management of substance abuse: process of translation and adaptation of instruments [web page on the Internet] Geneva, Switzerland: World Health Organization; 2012. Available from: http://www.who.int/substance_abuse/research_tools/translation/en/index.html. Accessed March 15, 2011.

Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology. 2005;64(6):992–995. PubMed

Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol. 1980;19(6):382–389. PubMed

Collin C, Wade D. Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry. 1990;53(7):576–579. PubMed PMC

Elovic E, Baerga E. Associated topics in physical medicine and rehabilitation: spasticity. In: Cuccurullo SJ, editor. Physical Medicine and Rehabilitation Board Review. New York: Demos Medical Publishing; 2004. pp. 743–750.

Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth Scale of muscle spasticity. Phys Ther. 1987;67(2):206–207. PubMed

Berg K, Wood-Dauphinee S, Williams JI. The Balance Scale: reliability assessment with elderly residents and patients with an acute stroke. Scand J Rehab Med. 1995;27(1):27–36. PubMed

Berg Balance Scale. American Academy of Health and Fitness. Available from: http://www.aahf.info/pdf/Berg_Balance_Scale.pdf. Accessed February 19, 2009.

Guarna F, Corriveau H, Chamberland J, Arsenault AB, Dutil E, Drouin G. An evaluation of the hemiplegic subject based on Bobath approach: Part I. The model. Scand J Rehab Med. 1988;20(1):1–4. PubMed

Davies PM. Steps to Follow: A Guide to the Treatment of Adult Hemiplegia; Based on the Concept of K. and B. Bobath. Berlin: Springer-Verlag; 1993.

Corriveau H, Guarna F, Dutil E, Riley E, Arsenault AB, Drouin G. An evaluation of the hemiplegic subject based on the Bobath approach: Part II. The evaluation protocol. Scand J Rehabil Med. 1988;20(1):5–11. PubMed

Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E, editors. Parkinson’s Disease and Movement Disorders. 2nd ed. Baltimore (MD): Williams and Wilkins; 1993. pp. 271–280.

Alusi SH, Worthington J, Glickman S, Findley LJ, Bain PG. Evaluation of three different ways of assessing tremor in multiple sclerosis. J Neurol, Neurosurg Psychiatry. 2000;68(6):756–760. PubMed PMC

Coulthard-Morris L. Clinical and rehabilitation outcome measures. In: Burks JS, Johnson KP, editors. Multiple Sclerosis: Diagnosis, Medical Management, and Rehabilitation. New York: Demos Medical Publishing; 2000. pp. 236–290.

Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–428. PubMed

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289–300.

R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012. Version 2.14.2 (2012-02-29), Available from: http://www.R-project.org/. Accessed March 4, 2012.

Revelle W. Package Psych: Procedures for Personality and Psychological Research. 1.0–92 ed. Evanston: Northwestern University; 2010. Available from: http://www.personality-project.org/r/book/psych.pdf. Accessed August 9, 2012.

Cameron D, Bohannon RW. Criterion validity of lower extremity Motricity Index scores. Clin Rehabil. 2000;14(2):208–211. PubMed

Gregson JM, Leathley MJ, Moore AP, Smith TL, Sharma AK, Watkins CL. Reliability of measurements of muscle tone and muscle power in stroke patients. Age Ageing. 2000;29(3):223–228. PubMed

Nuyens G, De Weerdt W, Ketelaer P, et al. Inter-rater reliability of the Ashworth Scale in multiple sclerosis. Clin Rehabil. 1994;8(4):286–292.

Blum L, Korner-Bitensky N. Usefulness of the Berg Balance Scale in stroke rehabilitation: a systematic review. Phys Ther. 2008;88(5):559–566. PubMed

World Health Organization (WHO) International Classification of Functioning, Disability and Health: ICF. Geneva, Switzerland: WHO; 2001.

Paltamaa J, West H, Sarasoja T, Wikström J, Mälkiä E. Reliability of physical functioning measures in ambulatory subjects with MS. Physiother Res Int. 2005;10(2):93–109. PubMed

Balcer LJ, Baier ML, Pelak VS, et al. New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler. 2000;6(3):163–171. PubMed

Bohannon RW, Andrews AW. Standards for judgments of unilateral impairments in muscle strength. Percept Mot Skills. 1999;89(3 Pt 1):878–880. PubMed

Damiano DL, Quinlivan JM, Owen BF, Payne P, Nelson KC, Abel MF. What does the Ashworth Scale really measure and are instrumented measures more valid and precise? Dev Med Child Neurol. 2002;44(2):112–118. PubMed

Platz T, Eickhof C, Nuyens G, Vuadens P. Clinical scales for the assessment of spasticity, associated phenomena, and function: a systematic review of the literature. Disabil Rehabil. 2005;27(1–2):7–18. PubMed

Dario A, Tomei G. Management of spasticity in multiple sclerosis by intrathecal baclofen. Acta Neurochir Suppl. 2007;97(Pt 1):189–192. PubMed

Ansari NN, Naghdi S, Moammeri H, Jalaie S. Ashworth scales are unreliable for the assessment of muscle spasticity. Physiother Theory Pract. 2006;22(3):119–125. PubMed

Ansari NN, Naghdi S, Arab TK, Jalaie S. The interrater and intra-rater reliability of the Modified Ashworth Scale in the assessment of muscle spasticity: limb and muscle group effect. Neuro Rehabilitation. 2008;23(3):231–237. PubMed

Hobart JC, Riazi A, Thompson AJ, et al. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88) Brain. 2006;129(Pt 1):224–234. PubMed

Cattaneo D, Jonsdottir J, Repetti S. Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil. 2007;29(24):1920–1925. PubMed

Cattaneo D, Regola A, Meotti M. Validity of six balance disorders scales in persons with multiple sclerosis. Disabil Rehabil. 2006;28(12):789–795. PubMed

Arsenault AB, Dutil E, Lambert J, Corriveau H, Guarna F, Drouin G. An evaluation of the hemiplegic subject based on the Bobath approach: Part III. A validation study. Scand J Rehabil Med. 1988;20(1):13–16. PubMed

Bain PG, Findley LJ, Atchison P, et al. Assessing tremor severity. J Neurol Neurosurg Psychiatry. 1993;56(8):868–873. PubMed PMC

Feys P, D’hooghe M, Nagels G, Helsen WF. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis. Mult Scler. 2009;15(3):371–378. PubMed

Feys PG, Davies-Smith A, Jones R, et al. Intention tremor rated according to different finger-to-nose test protocols: a survey. Arch Phys Med Rehabil. 2003;84(1):79–82. PubMed

Plaha P, Khan S, Gill SS. Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry. 2008;79(5):504–513. PubMed

Bryant JA, De Salles A, Cabatan C, Frysinger R, Behnke E, Bronstein J. The impact of thalamic stimulation on activities of daily living for essential tremor. Surg Neurol. 2003;59(6):479–484. PubMed

Hooper J, Taylor R, Pentland B, Whittle IR. Rater reliability of Fahn’s tremor rating scale in patients with multiple sclerosis. Arch Phys Med Rehabil. 1998;79(9):1076–1079. PubMed

Loudon JK, Goist HL, Loudon KL. Genu recurvatum syndrome. J Orthop Sports Phys Ther. 1998;27(5):361–367. PubMed

Basaglia N, Mazzini N, Boldrini P, Bacciglieri P, Contenti E, Ferraresi G. Biofeedback treatment of genu-recurvatum using an electrogoniometric device with an acoustic signal: one-year follow-up. Scand J Rehabil Med. 1989;21(3):125–130. PubMed

Trueblood PR, Walker JM, Perry J, Gronley JK. Pelvic exercise and gait in hemiplegia. Phys Ther. 1989;69(1):18–26. PubMed

Chao EY, Laughman RK, Schneider SS, Stauffer RN. Normative data of knee joint motion and ground reaction forces in adult level walking. J Biomech. 1983;16(3):219–233. PubMed

Ekstrand J, Wiktorsson M, Oberg B, Gillquist J. Lower extremity goniometric measurements: a study to determine their reliability. Arch Phys Med Rehabil. 1982;63(4):171–175. PubMed

Rheault W, Miller M, Nothnagel P, Straessle J, Urban D. Intertester reliability and concurrent validity of fluid-based and universal goniometers for active knee flexion. Phys Ther. 1988;68(11):1676–1678. PubMed

Pomeroy VM, Evans E, Richards JD. Agreement between an electrogoniometer and motion analysis system measuring angular velocity of the knee during walking after stroke. Physiotherapy. 2006;92(3):159–165.

Solari A, Radice D, Manneschi L, Motti L, Montanari E. The multiple sclerosis functional composite: different practice effects in the three test components. J Neurol Sci. 2005;228(1):71–74. PubMed

Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain. 1999;122(Pt 5):871–882. PubMed

Rosti-Otajärvi E, Hämäläinen P, Koivisto K, Hokkanen L. The reliability of the MSFC and its components. Acta Neurol Scand. 2008;117(6):421–427. PubMed

Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler. 1995;1(1):37–47. PubMed

Rudick RA, Cutter G, Baier M, et al. Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS. Neurology. 2001;56(10):1324–1330. PubMed

Cohen JA, Fischer JS, Bolibrush DM, et al. Intrarater and interrater reliability of the MS functional composite outcome measure. Neurology. 2000;54(4):802–806. PubMed

Syndulko K, Ke D, Ellison GW, Baumhefner RW, Myers LW, Tourtellotte WW, for Multiple Sclerosis Study Group Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Mult Scler. 1996;2(3):142–156. PubMed

Real-World Goal Setting and Use of Outcome Measures According to the International Classification of Functioning, Disability and Health: A European Survey of Physical Therapy Practice in Multiple Sclerosis